Showing results (201-210 of 260) with videos related to
Sort By:
Pageof 26
Experimental Dermatology|November 15, 2017
Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoidChristian D Sadik, Julia Bischof, Nina van Beek, et al.Frontiers in Immunology|September 5, 2022
The relevance of complement in pemphigoid diseases: A critical appraisalCristian Papara, Christian M Karsten, Hideyuki Ujiie, et al.The Journal of Investigative Dermatology|March 2, 2013
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activationLars Hellberg, Unni K S R L Samavedam, Karoline Holdorf, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 6, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case seriesKaan Yilmaz, Stephanie Goletz, Christoph M Hammers, et al.Journal of Cell Science|January 3, 2023
Meeting report - Desmosome dysfunction and disease: Alpine desmosome disease meetingVolker Spindler, Brenda Gerull, Kathleen J Green, et al.Frontiers in Immunology|December 12, 2019
Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus FoliaceusLuana Caroline Oliveira, Gabriela Canalli Kretzschmar, Andressa Cristina Moraes Dos Santos, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.Journal of the American Academy of Dermatology|November 22, 2023
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoidStephanie Goletz, Manuela Pigors, Tina Rastegar Lari, et al.Experimental Dermatology|June 16, 2016
Monopathogenic vs multipathogenic explanations of pemphigus pathophysiologyA Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.Pageof 26